Target intelligence / Profile preview

Silk fibroin (SF)

Target
SF
Molecular classification
Structural protein, Fibrous protein, β-keratin-related protein
01

Overview

Silk fibroin is the main structural protein component of silk fibers produced by silkworms and certain other insects. It consists primarily of heavy and light polypeptide chains (the heavy chain ~390 kDa and the light chain ~26 kDa, joined by a disulfide bond) and is associated with a glycoprotein (P25, ~25-30 kDa) in a 6:6:1 molar ratio. The protein’s sequence is highly repetitive and rich in glycine, alanine, and serine, which contribute to its highly organized anti-parallel β-sheet secondary structure. This structure imparts silk fibroin with remarkable mechanical properties, including strength, elasticity, and biocompatibility. Silk fibroin is widely studied and used as a biomaterial for medical and engineering applications—such as tissue scaffolds, wound dressing, and drug delivery matrices—because of its mechanical performance and biocompatibility. It is not, however, an endogenous signaling protein or molecular target in human pharmacology, nor is it involved in canonical disease signaling pathways.

Other names
FibroinSilk proteinBombyx mori silk fibroin
02

Biological functions

Structural support in silk fibersProvides mechanical strength, elasticity, and toughness for cocoonsBiomaterial scaffold for tissue engineering and regenerative medicine (when used exogenously)
03

Disease associations

Not known to be involved in human diseases
04

Safety considerations

Potential for mild immunogenic or inflammatory reaction in some individuals when implantedRisk of contamination or transmission of infectious agents if not properly processedRemoval of sericin is necessary to reduce immunogenicity

Beyond the preview

Go deeper on Silk fibroin (SF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Silk fibroin (SF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call